Azienda Policlinico Umberto I
58
10
11
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
3.4%
2 terminated/withdrawn out of 58 trials
93.3%
+6.8% vs industry average
33%
19 trials in Phase 3/4
0%
0 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (58)
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Role: collaborator
Ditan Acute tReatments: Effectiveness and Tolerability (DART)
Role: collaborator
Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
Role: collaborator
Gepant treAtments: EffectIveNess and tolERability (GAINER)
Role: collaborator
Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study)
Role: collaborator
Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart Failure
Role: collaborator
Next Generation Sequencing Analysis of Patients with Spontaneous Dissection of Cervical Arteries
Role: collaborator
DPP4-Inhibitors and Bone Metabolism in Diabetes
Role: lead
Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT
Role: collaborator
Node Positive Cervical Cancer Treated by Neoadjuvant Chemotherapy Plus Radical Surgery: a Single Center Experience
Role: lead
Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
Role: collaborator
Relieving Chronic Pain: Psychosomatic Mechanisms and Psychological Interventions in Fibromyalgia and Chronic Headache
Role: collaborator
Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes
Role: collaborator
PFO tRanscatether Occlusion Long-term Outcomes National Group (PROLONG) Registry
Role: collaborator
Effectiveness and Tolerability of Eptinezumab
Role: collaborator
Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study
Role: collaborator
Characterization of Different Phenotypes of Microvascular Dysfunction and Their Impact on Angina Severity in Patients With Chronic Angina in the Absence of Obstructive Coronary Artery Disease.
Role: collaborator
Aorto-iliac Occlusion Treatment With ShorT Unibody aorTic Endograft - ASTUTE Study
Role: collaborator
Movement Analysis in Musculoskeletal Oncology: a Pilot Study
Role: collaborator
Quality of Life and Voice Perception in Patients Laryngoctomized Phonatory Wearers
Role: collaborator